AbbVie has announced that its drug, Rinvoq, successfully met the primary endpoint in a second Phase 3 clinical trial aimed at treating severe alopecia areata. This...
SentientLight, a company based in Hayden, Idaho, is seeking to raise $10 million to expand its operations following the successful validation of its non-drug pain relief...
The U.S. Food and Drug Administration (FDA) Commissioner Marty Makary has publicly urged former Center for Biologics Evaluation and Research (CBER) head Vinay Prasad to reconsider...
